Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

LGVN

+ Watchlist+ Portfolio

Longeveron Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.11
52-Week Range
$1.31 – $12.30
Market Cap
$6.48M
P/E (TTM)
—
EPS (TTM)
-7.95
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.78
PEG Ratio
—
Return on Equity
-203.61%
Return on Assets
-90.95%
Gross Margin
69.76%
Operating Margin
-1975.99%
Profit Margin
0.00%
Current Ratio
2.63
Debt/Equity
0.06
Total Debt
$581.00K
Free Cash Flow
$-11.60M
Revenue Growth
-9.20%
Earnings Growth
—
Enterprise Value
$-27.05K

Market Snapshot

About

Longeveron Inc. is a clinical-stage biotechnology company developing regenerative medicine therapies based on Medicinal Signaling Cells (MSCs). The company's lead product candidate targets aging-related and life-threatening conditions including Alzheimer's disease, aging frailty, and acute respiratory distress syndrome. Longeveron's research focuses on harnessing the body's natural healing mechanisms to address diseases with significant unmet medical needs.